NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced today its Chicago dispensary, located at 4758 N. Milwaukee Ave., has completed the transition to the Company’s award-winning Cannabist retail experience.
“Illinois was one of the first states to launch Cannabist, so we’re thrilled to complete our rebrand in this important market,” said Andrew Bayly, Director of Operations – Midwest, Columbia Care. “Our product brands are some of the most sought after in the state, so it’s only fitting that we elevate our retail experience to match that demand. Cannabist offers a higher experience to anyone who comes into our dispensaries through thoughtful design and customer service as well as innovative technology. We’re grateful to the local officials and Illinois Department of Financial and Professional Regulation for helping us complete this transition.”
As part of the Cannabist update, the dispensary expanded its retail footprint by nearly 1,700 square feet to serve the growing number of medical patients and adult use customers. Columbia Care’s Villa Park location flipped to Cannabist in June 2021. The Company also operates a 32,802-square-foot cultivation center in Aurora.
Cannabist Chicago offers several of Columbia Care’s brands including Seed & Strain, Triple Seven and Classix, as well as Tyson 2.0, for which Columbia Care is the brand’s cultivation, manufacturing and distribution partner in the market. Customers also have access to Columbia Care’s proprietary cannabis discovery tool, Forage, both in-store and online to help find strains and products to fit their needs.
Columbia Care currently wholesales to more than 90% of dispensaries in Illinois. The Company was the first to introduce Dablicators and Dab Tabs to the market, and was the first to offer multi-strain pre-roll packs. Several of the Company’s flower strains won gold, silver and bronze awards from the 2021 High Times Illinois Cannabis Cup.
For more information, visit www.gocannabist.com/chicago.
About Columbia Care
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original multi-state providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.
Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company’s ability to execute on retail, wholesale, brand and product initiatives in Illinois. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. These risks, uncertainties and other factors include, among others, favorable operating and economic conditions; obtaining and maintaining all required licenses and permits; favorable production levels and sustainable costs from the Company’s operations; and the level of demand for cannabis products, including the Company’s products sold by third parties. In addition, securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Form 10-K dated March 31, 2022, filed with U.S. Securities and Exchange Commission and with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and as otherwise described from time to time in documents filed by the Company with Canadian and U.S. securities regulatory authorities.